KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

CRISPR Therapeutics AG (CRSP) Interest & Investment Income: 2015-2016

Historic Interest & Investment Income for CRISPR Therapeutics AG (CRSP) over the last 2 years, with Dec 2016 value amounting to -$8.1 million.

  • CRISPR Therapeutics AG's Interest & Investment Income rose 101.01% to $1,000 in Q4 2016 from the same period last year, while for Dec 2016 it was -$8.1 million, marking a year-over-year change of. This contributed to the annual value of -$8.1 million for FY2016, which is 7353.70% down from last year.
  • As of FY2016, CRISPR Therapeutics AG's Interest & Investment Income stood at -$8.1 million, which was down 7,353.70% from -$108,000 recorded in FY2015.
  • In the past 5 years, CRISPR Therapeutics AG's Interest & Investment Income registered a high of -$108,000 during FY2015, and its lowest value of -$8.1 million during FY2016.
  • Its 2-year average for Interest & Investment Income is -$4.1 million, with a median of -$4.1 million in 2015.
  • Data for CRISPR Therapeutics AG's Interest & Investment Income shows a maximum YoY crashed of 7,353.70% (in 2016) over the last 5 years.
  • CRISPR Therapeutics AG's Interest & Investment Income (Yearly) stood at -$108,000 in 2015, then tumbled by 7,353.70% to -$8.1 million in 2016.